OBJECTIVE: Chlorhexidine gluconate (CHG) is a common and safe antimicrobial agent and has been used widely in hand hygiene and skin disinfection; however, whether daily bathing with CHG results in the reduced acquired infection of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) remains inconclusive. METHODS: We did a meta-analysis searching PubMed, Embase and the Cochrane Central Register database for available studies. Primary outcomes were acquired infection of MRSA, VRE. RESULTS: In all, twelve articles were available in this review. We found that daily application of chlorhexidine bathing would significantly low the acquired colonization of MRSA [incidence rate ratio (IRR) =0.58, 95% confidence interval (CI): 0.41-0.82] or VRE (IRR =0.51, 95% CI: 0.36-0.73). Remarkably, the using of CHG bathing would significantly reduce the MRSA infection (IRR =0.56, 95% CI: 0.37-0.85), MRSA ventilator associated pneumonia (VAP) (IRR =0.22, 95% CI: 0.07-0.64) and VRE infection (IRR =0.57, 95% CI: 0.33-0.97). No significant publication bias was found in this meta-analysis. CONCLUSIONS: The application of CHG bathing would significantly decrease acquired infection of MRSA or VRE, which may be an important complementary intervention to barrier precautions.
OBJECTIVE:Chlorhexidine gluconate (CHG) is a common and safe antimicrobial agent and has been used widely in hand hygiene and skin disinfection; however, whether daily bathing with CHG results in the reduced acquired infection of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) remains inconclusive. METHODS: We did a meta-analysis searching PubMed, Embase and the Cochrane Central Register database for available studies. Primary outcomes were acquired infection of MRSA, VRE. RESULTS: In all, twelve articles were available in this review. We found that daily application of chlorhexidine bathing would significantly low the acquired colonization of MRSA [incidence rate ratio (IRR) =0.58, 95% confidence interval (CI): 0.41-0.82] or VRE (IRR =0.51, 95% CI: 0.36-0.73). Remarkably, the using of CHG bathing would significantly reduce the MRSA infection (IRR =0.56, 95% CI: 0.37-0.85), MRSA ventilator associated pneumonia (VAP) (IRR =0.22, 95% CI: 0.07-0.64) and VRE infection (IRR =0.57, 95% CI: 0.33-0.97). No significant publication bias was found in this meta-analysis. CONCLUSIONS: The application of CHG bathing would significantly decrease acquired infection of MRSA or VRE, which may be an important complementary intervention to barrier precautions.
Authors: R Monina Klevens; Jonathan R Edwards; Fred C Tenover; L Clifford McDonald; Teresa Horan; Robert Gaynes Journal: Clin Infect Dis Date: 2005-12-19 Impact factor: 9.079
Authors: Glenn Ridenour; Russell Lampen; Jeff Federspiel; Steve Kritchevsky; Edward Wong; Michael Climo Journal: Infect Control Hosp Epidemiol Date: 2007-08-01 Impact factor: 3.254
Authors: Ryan C Johnson; Carey D Schlett; Katrina Crawford; Jeffrey B Lanier; D Scott Merrell; Michael W Ellis Journal: J Clin Microbiol Date: 2015-08-19 Impact factor: 5.948
Authors: J A McKinnell; S J Eells; E Clark; D D Rand; G T Kiet; R Macias-Gil; J M Mendez; S S Huang; E N Milefchik; L G Miller Journal: Epidemiol Infect Date: 2017-06-09 Impact factor: 2.451
Authors: Kristen V Dicks; Eric Lofgren; Sarah S Lewis; Rebekah W Moehring; Daniel J Sexton; Deverick J Anderson Journal: Infect Control Hosp Epidemiol Date: 2016-02-10 Impact factor: 3.254
Authors: Lona Mody; Kyle J Gontjes; Marco Cassone; Kristen E Gibson; Bonnie J Lansing; Julia Mantey; Mohammed Kabeto; Andrzej Galecki; Lillian Min Journal: JAMA Netw Open Date: 2021-07-01